D.E. Shaw & Co
YARW

D.E. Shaw & Co’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

D.E. Shaw & Co’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-8
Closed -$231K – 4007
2018
Q2 		$231K Buy
+8
New +$311K ﹤0.01% 3491

Other funds holding YARW

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co's YARW Position: Q3 2018 in Review

D.E. Shaw & Co sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q3 2018, closing a stake of 8 shares — an estimated $231K sold.

D.E. Shaw & Co first reported a position in YARW in Q2 2018 and held it in 1 quarter. The position peaked at $231K in Q2 2018. 42 funds tracked by Wall St. Rank hold YARW as of Q3 2018.

  • D.E. Shaw & Co reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • D.E. Shaw & Co sold 8 Yarrow Bioscience, Inc. Common Stock shares in Q3 2018, an estimated $231K.
  • D.E. Shaw & Co first reported a position in Yarrow Bioscience, Inc. Common Stock in Q2 2018 and held it in 1 quarter.
  • D.E. Shaw & Co's Yarrow Bioscience, Inc. Common Stock position peaked at $231K in Q2 2018.
  • 42 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q3 2018.

Based on D.E. Shaw & Co's 13F filing for Q3 2018, filed 14 Nov 2018.